Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Stock picking requires research and discipline; assess whether your time, resources, and goals justify active selection over passive options.
17,093 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A mid-2026 move by a hedge fund to exit EPAM Systems sparked questions about portfolio risk and disclosure. This guid...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...
Two giants in the investing world, KKR and ROWE PRICE, offer very different paths to growth. This guide breaks down w...
Target shares surged to a fresh all-time high after a robust Q1 report, sparking questions about how long the rally c...
A new milestone for Uber signals more than a single quarter of growth. With gross bookings up 25% and a bold autonomo...
Tech giants swing on headlines. This guide unpacks why meta stock dropped then, how the rebound happened, and what in...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
As AI expands data center demand, Micron sits at the center of memory supply. This guide breaks down the odds for 202...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...